Dendritic cells in sepsis: An approach to post-infectious immunosuppression;Células dendríticas en la sepsis: Una aproximación a la inmunosupresión postinfecciosa

Medicina Intensiva

Volumn 34, Issue 8, 2010, Pages 559-566

  Sirgo, G ^a   Claramonte, R ^a   Chanovas M ^a   Esteban, F ^a   Forcadell, I ^a   Luna, J ^a   Masdeu, G ^a   Ramon Vazquez J ^a   Artigas, A ^b  

^a HOSPITAL VERGE DE LA CINTA   (Spain)

^b Servicio de Oncología Médica   (Spain)

Author keywords

Dendritic cells; Immunosuppression; Sepsis

Indexed keywords

ANTIGEN PRESENTING CELL; CELL COMMUNICATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; HOSPITAL INFECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; PROGNOSIS; SEPSIS; SHORT SURVEY; T LYMPHOCYTE;

EID: 77957754678     PISSN: 02105691     EISSN: 15786749     Source Type: Journal    
DOI: 10.1016/j.medin.2009.11.005     Document Type: Short Survey

References (47)

1. Ferrer R., Navas A., Adda M., Artigas A. Papel de la coagulación en la fisiopatología de la lesión pulmonar aguda. Paralelismo con la sepsis. Med Intensiva 2008, 32:304-311.
2. Esteban A., Frutos-Vivar F., Ferguson N.D., Peñuelas O., Lorente J.A., Gordo F., et al. Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward. Crit Care Med 2007, 35:1284-1289.
3. Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554.
4. Hotchkiss R.S., Kart I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
5. Eichacker P.Q., Parent C., Kalil A., Esposito C., Cui X., Banks S.M., et al. Risk and the efficacy of antiinflammatory agents in sepsis: Retrospective and confirmatory studies. Am J Respir Crit Care Med 2002, 166:1197-1205.
6. Vicent J.L., Sun Q., Dubois M.J. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 2002, 34:1084-1093.
7. Ferrer R., Artigas A., Levy M., Blanco J., González-Díaz G., Garnacho-Montero J., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 2008, 299:2294-2303.
8. Perl M., Cheng C.S., Garber M., Huang X., Ayala A. Contribution of anti-inflammatory/immune suppresive processes to the patthology of sepsis. Front Biosci 2006, 11:272-299.
9. Bone R.C. Sir Isaac Newton, sepsis, SIRS and CARS. Crit Care Med 1996, 24:1125-1128.
10. Huan X., Venet F., Chung C.S., Lomas-Neira J., Ayala A. Changes in dendritic cell function in the immune response to sepsis. Expert Opin Biol Ther 2007, 7:929-938.
11. Quartin A.A., Schein R.M., Kett D.H., Peduzzi P.N. Magnitude and duration of the effect of sepsis on survival. JAMA 1997, 277:1058-1063.
12. Pagano H., Tilney N.L. Chronic allograft failure: The clinical problem. Am J Med Sci 1997, 313:305-309.
13. Kobayashi M., Takahashi H., Sanford A., Herndon D.N., Pollard R.B., Suzuk F. An increase in the susceptibility of burned patients to infections complications due to impaired production of macrophage inflammatory protein 1 alpha. J Immunol 2002, 169:4460-4466.
14. Lemanske R.F. The childhood origins of asthma (COAST) study. Pediatr Allergy Immunol 2002, 13:38-43.
15. Steinman R.M., Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. Morphology, quantitation, tissue distribution. J Exp Med 1973, 137:1142-1162.
16. Ardavin C., Martínez del Hoyo G., Martín P., Anjuere F., Anjuère F., Arias C.F. Origin and differentiation of dendritic cells. Trends Immunol 2001, 22:691-700.
17. Shortman K., Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002, 2:151-161.
18. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J. Immunobiology of dendritic cells. Ann Rev Immunol 2000, 18:767-811.
19. Reichardt P., Dornbach B., Gunzer M. The molecular makeup and function of regulatory and effector synapses. Immunol Rev 2007, 218:165-177.
20. Liu Y.J. Dendritic cell subsets and their functions in innate and adaptive immunity. Cell 2001, 106:259-262.
21. Della Bella S., Giannelli S., Taddeo S., Presicce P., Villa M.L. Application of six-color flow cytometry for the assessment of dendritic cell responses in whole blood assays. J Immunol Methods 2008, 339:153-164.
22. Hashimoto S.I., Suzuki T., Nagai S., Yamashita T., Toyoda N., Matsushima K. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 2000, 96:2206-2214.
23. Wysocka M., Robertson S., Riemann H., Caamano J., Hunter C., Mackiewicz A., et al. Il-12 supression during experimental endotoxin tolerance: Dendritic cell loss and macrophage hyporesponsiveness. J Immunol 2001, 166:7504-7513.
24. Della Bella S., Crosignani A., Riva A., Presicce P., Benetti A., Longhi R., et al. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection. Immunology 2007, 121:283-292.
25. Ryan K.R., Hong M., Arkwright P.D., Gennery A.R., Costigan C., Domínguez M., et al. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED. Clin Exp Immunol 2008, 154:406-414.
26. Monneret G., Debard A.L., Venet F., Bohe J., Hequet O., Bienvenu J., et al. Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 2003, 7:2068-2071.
27. Trinchieri G. IL-12 and the regulation of innate resistance and adaptative immunity. Nat Rev Immunol 2003, 3:133-146.
28. Nguyen K.B., Salazar-Mather T.P., Dalod M.Y., Van Deusen J.B., Wei X.Q., Liew F.Y., et al. Coordinated and distinct roles for IFN-αΒ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002, 169:4279-4287.
29. Takeuchi O., Hoshino K., Akir S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000, 165:5392-5396.
30. Hsieh C.S., Macatonia S.E., Tripp C.S., Wolf S.F., O'Garra A., Murphy K.M. Development of Th1 CD4+T cells through IL-12 produced by Listeria-induced macrophages. Science 1993, 260:547-549.
31. Wysocka M, Robertson S, Riemann H, Caamano J, Hunter C, Mackiewicz A, et al. IL-12 suppression during experimental endotoxin tolerance: Dendritic cell loss and macrophage hyperesponsiveness. J Immunol. 2001;166:7504-13.
32. Della Bella S., Gennaro M., Vaccari M., Ferraris C., Nicola S., Riva A., et al. Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer 2003, 89:1463-1472.
33. Benjamain CF, Lundy SK, Lukacs NW, Hogaboam CM, Kunkel SL. Reversal long-term sepsis-induced immunosuppresion by dendritic cells. Blood. 105:3588-95.
34. Wen H., Hogaboam C.M., Gauldie J., Kunkel S.L. Severe sepsis exacerbates cell-mediated immunity in the lung due to an altered dendritic cell cytokine profile. Am J Pathol 2006, 168:1940-1950.
35. Tinsley K.W., Grayson M.H., Swanson P.E., Drewry A.M., Chang K.C., Karl I.E. Sepsis induces apoptosis and profound deplection of splenic interdigitating and follicular dendritic cells. J Immunol 2003, 171:909-914.
36. Ding Y., Chung C.S., Newton S., Chen Y., Carlton S., Albina J.E., et al. Polymicrobial sepsis induces divergent effects on splenic and peritoneal dendritic cell function in mice. Shock 2004, 22:137-144.
37. Flohe S.B., Agrawal H., Schmitz D., Gertz M., Flohe S., Schade F.U. Dendritic cells during polymicrobial sepsis rapidly mature but fail to initiate a protective Th-1-type immune response. J Leukoc Biol 2006, 79:473-481.
38. Hotchkiss R.S., Tinsley K.W., Swanson P.E., Grayson M.H., Osborne D.F., Wagner T.H., et al. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 2002, 168:2493-2500.
39. Guisset O., Dilhuydy M.-S., Thiébaut R., Lefèvre J., Camou F., Sarrat A., et al. Decrease in circulating dendritic cells predicts fatal outcome in septic shock. Intensive Care Med 2007, 33:148-152.
40. Grimaldi D., Louis S., Sirgo G., Rousseau C., Pene F., Chiche J.D. Circulating myeloid and plasmocytoid dendritic cells are strongly diminished in septic patints. Crit Care 2008, 12:36.
41. Efron P.A., Martins A., Minninch D., Tinsley K., Ungaro R., Bahjat F.R., et al. Characterization of the systemic loss of dendritic cells in murine lymph nodes during polymicrobial sepsis. J Immunol 2004, 173:3035-3043.
42. Steinman R.M. Dendritic cells: Understanding immunogenicity. Eur J Immunol 2007, 37:S53-S60.
43. Scumpia P.O., Mcauliffe P.F., O'malley K.A., Ungaro R., Uchida T., Matsumoto T., et al. CD11c (+) dendritic cells are required for survival in murine polymicrobial sepsis. J Immunol 2005, 175:3282-3286.
44. Pène F., Zuber B., Courtine E., Rousseau C., Ouaaz F., Toubiana T., et al. Dendritic cells modulate lung response to Pseudomonas aeruginosa in a murine model of sepsis-induced immune dysfunction. J Immunol 2008, 181:8513-8520.
45. Toliver-Kinsky T.E., Cui W., Murphey E.D., Lin C., Sherwood E.R. Enhancement of dendritic cell production by fms-like tyrosine kinase-3 ligand increases the resistance of mice to a burn wound infection. J Immunol 2005, 174:404-410.
46. Wysocka M., Montaner L.J., Karp C.L. Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysis. J Immunol 2005, 174:7398-7402.
47. Fujita S., Seino K., Sato K., Sato Y., Eizumi K., Yamashita N., et al. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 2006, 107:3656-3664.